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CASE REPORT
Breaking the pain cycle successfully in a child with severe pain due to recurrent
pancreatitis: A case report
Ali Sarfraz Siddiqui, Mansoor Chandio

Abstract
Abdominal pain, due to pancreatic diseases like
idiopathic recurrent pancreatitis and chronic pancreatitis,
is difficult to manage with medications alone in some
patients. The Coeliac plexus innervates abdominal organs
including the liver, gallbladder, pancreas, etc. We are
presenting a case of the successful pain man-agement of
a 13-year-old boy with recurrent pancreatitis, by the
application of coeliac plexus block. The patient was
admitted to the hospital with severe abdominal pain in
August 2019. Multimodal analgesia was provided to
manage his pain, but he continued to have moderate to
severe pain in the abdomen. So, he was scheduled for
coeliac plexus block under fluoroscopy in the operating
room. Block Procedure was performed with standard
monitoring and under conscious sedation bilaterally, via
paramedian technique at the level of L1 using 22G Chiba
needle. The injection Ropivicaine 0.25% with
dexamethasone was injected on each side. After the
procedure, his pain was significantly reduced and he was
discharged on oral medications after two days.
Keywords: Coeliac plexus block, Recurrent pancreatitis,
Pain management tech-nique.
DOI: https://doi.org/10.47391/JPMA.302

Introduction
Pancreatic pathologies have a debilitating disease course
in which pain is one of the most disturbing symptoms for
the patient that affects the quality of life.1 Abdominal pain
due to pancreatic diseases like carcinoma, idiopathic
recurrent pancreatitis, and chronic pancreatitis are difficult
to manage on medications alone. Most of the patients
cannot tolerate the side effects of medications. This leads
to an increased frequency of hospital admissions,
morbidity, and substantial financial implications.
The Coeliac plexus innervates abdominal organs
including the liver, gallbladder, stomach, pancreas,
spleen, both kidneys, entire small bowel and the first twothirds of the large bowel. The Coeliac plexus is formed by
coeliac, aortic, renal, and superior mesenteric ganglia. It is
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located anterolateral to the aorta at L1 vertebra level.2 The
Coeliac plexus contains both sympathetic and
parasympathetic nerve fibres with sympathetic
predominant. Sympathetic fibres of the coeliac plexus
originate from anterolateral horn of the spinal cord at T5
to T12 level.3 Pain originating from the pancreas is carried
through sympathetic fibres at the level of T12 to L1.
Different mechanisms are involved in pain transmission to
higher centres like direct infiltration of nerve,
inflammation and auto-digestion of pancreas and
surrounding tissues, and neural sheath, the mass effects
of which are due to pseudocyst.4
The Coeliac plexus block is usually offered to adult
patients with moderate to severe pain due to pancreatic
pathology.5 However, coeliac plexus block in paediatric
patients with pancreatic disease is infrequently
reported. Limited data is available on the use of coeliac
plexus block in paediatric patients. We are presenting a
case of the successful pain management of a child with
recurrent pancreatitis by the application of the coeliac
plexus block.

Case Report
A 13-year-old boy weighing 60 kg, a known case of
recurrent pancreatitis was admitted to the Aga Khan
University Hospital Karachi with severe abdominal pain in
August 2019. The patient had a history of hospitalisation
multiple times for pain management due to multiple
episodes of epigastric pain for the last two years that were
managed conservatively. This time once again, the
patient was admitted to the hospital for his pain
management. Workup was done which showed elevated
lipase and amylase levels. CT scan of the abdomen was
repeated which showed acute pancreatitis with pseudocyst formation.
The paediatric team requested a pain management team
for evaluation and pain management. On assessment, the
patient had severe epigastric pain; the pain was radiating
to the back with pain intensity of 8/10 on the numeric
pain rating scale. The pain was sharp, stabbing in nature,
continuous, and aggravated with movements, and
relieved minimally with medications. For pain
management, patient-controlled analgesia with tramadol
Vol. 71, No. 9, September 2021

A. S. Siddiqui, M. Chandio

was started (10 mg per hour background infusion, 10mg
of bolus dose and 10 minutes of lockout time was set).
Intravenous paracetamol 800mg every 6 hours and
pregabalin 50mg per os at night was also started. By the
next day, severity of pain had reduced to 6/10 on the
above pain management regimen.
A detailed discussion was carried out with the pain and
paediatric teams regarding the intervention of pain
management options. After a detailed discussion, it was
decided to offer coeliac plexus block for pain
management. The patient and his father were counselled
about coeliac plexus block under local anaesthesia and
conscious sedation using fluoroscopy, that they both
agreed to. Written informed consent was taken from the
father, with the risks and benefits explained.
The patient was scheduled for coeliac plexus block
under fluoroscopy in the operating room. After six hours
nil per oral as per plan, the patient was shifted to the
operating room to receive the block. Lactated Ringer's
solution was started at 100 ml per hour and standard
monitoring was applied. Patient was positioned prone
and oxygen at 5 litres per minute via face mask was
started. For sedation, the injection Propofol 50mg was
given in incremental doses of 10mg and intravenous
nalbuphine 5mg was given for analgesia. After all
aseptic measures, the injection lidocaine 2% 5ml was
applied for local anaesthesia at the level of L1. Under
fluoroscopic guidance, coeliac plexus block was
performed bilaterally via para-median technique at the
level of L1 using 150mm 22G Chiba needle. The injection
Ropivicaine 0.25% 15mls with 2mg dexamethasone was
injected on each side.
The patient remained stable throughout the procedure
and was shifted to the recovery room. Pain was
significantly reduced to 1/10 immediately after the
procedure. After 30 minutes the patient was shifted to
the ward. Patient was followed in the ward next day for
pain score and any possible complications. The patient
remained pain-free for two days and was discharged for
home in stable condition with oral Tramadol 50mg twice
daily (if needed) and Tab. Pregabalin 50mg twice daily.
There were follow-ups of the patient in the outpatient
clinic after two weeks and due to mild pain, was advised
to continue with pregablin 50mg every night for 4
weeks. Upon a telephonic follow-up after 4 weeks, the
patient was pain-free without any medication needed.

Discussion
Paediatric patients with visceral abdominal pain due to
cancer or chronic diseases of the upper abdomen are
usually managed with pharmacological agents. However,
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in adult patients, coeliac plexus block is often applied if
conservative pain management fails to control moderate
to severe abdominal pain. Physicians can make use of
this effective technique to manage pain in paediatric
patients.
Berde et al.6 reported coeliac plexus block in severe
refractory abdominal pain in a three years old patient due
to hepatoblastoma, which improved the overall quality of
life of the patient. Staats et al.7 reported the use of coeliac
plexus block in a seven year old girl with metastatic
neuroblastoma. The patient remained pain-free for
almost five weeks.
Due to anatomical variations and to confirm the spread
of medication around the coeliac plexus, Goldschneider
et al.8 reported the successful use of a new radiologic
technique called three-dimensional rotational
angiography for the performance of retrocrural coeliac
plexus block in three children with abdominal pain
arising due to different pathologies. A significant pain
reduction after coeliac plexus block was observed in all
three cases.
A retrospective case series was published by Anghelescu
et al.9 in which the coeliac plexus block was carried out
under Computed tomography (CT) guided imaging. This
case series has four patients of different age's viz. 8-year
old (Rhabdo-myosarcoma), 14-year old (hepatoblastoma),
19-year old (tumour of adrenal) and 20-year old
(rhabdomyosarcoma). This case series also yielded
encouraging results in terms of successful blocks under
CT guidance and decreased pain scores and reductions in
morphine equivalent daily (MED) within 1 week of coeliac
plexus block.
A relatively novel approach called therapeutic endoscopic
ultrasonography (EUS) use has been reported in case
series by Jia et al.10 in which they demonstrated 6
successful paediatric therapeutic EUS procedures,
including a coeliac plexus block for pain management in
chronic pancreatitis.
In this case, we performed fluoroscopy guided
percutaneous diagnostic coeliac plexus block in a patient
with a history of recurrent pancreatitis which was successful without any complications. The dosage of local
anaesthetic was according to the weight of the patient.
Bilaterally coeliac plexus was targeted under fluoroscopy.
The additional challenge that was faced during the
procedure is the non-cooperation of the child; so
intravenous conscious sedation was used.

Conclusion
A paediatric patient with moderate to severe abdominal
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pain benefitted from coeliac plexus block. This improved
the quality of life and decreased dependence on opioids
and their side effects.
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